Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: YH4808 100 mgDrug: YH4808 300 mg
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 44
- Registration Number
- NCT01520012
- Locations
- 🇰🇷
Yuhan Corporation, Seoul, Korea, Republic of
Safety and Efficacy of YH14617 in Diabetes Mellitus
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 84
- Registration Number
- NCT01507038
- Locations
- 🇰🇷
Yuhan, Seoul, Korea, Republic of
A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease
Phase 2
Completed
- Conditions
- Chronic Periodontitis
- Interventions
- Drug: YH14642 500mg TabDrug: PlaceboDrug: INSADOL[Zea mays L. extract] 35mg TabDrug: DENTISTA[Doxycycline hyclate] 20mg Cap
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 162
- Registration Number
- NCT01499225
- Locations
- 🇰🇷
Seoul National University Dental Hospital, Seoul, Korea, Republic of
Safety and Efficacy of YHD001 in Asthma
Phase 2
Completed
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 56
- Registration Number
- NCT01424124
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Efficacy of YHD1023 in Erectile Dysfunction
- First Posted Date
- 2011-08-25
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 104
- Registration Number
- NCT01423370
- Locations
- 🇰🇷
Yuhan Corporation, Seoul, Korea, Republic of
Comparative Pharmacokinetics of YH14659
Phase 1
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- First Posted Date
- 2011-08-23
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 44
- Registration Number
- NCT01422109
- Locations
- 🇰🇷
Yuhan Corporation, Seoul, Korea, Republic of
Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2011-08-22
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 28
- Registration Number
- NCT01420913
- Locations
- 🇰🇷
Seoul ST.Mary Hospital, Seoul, Korea, Republic of
Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
Phase 2
Completed
- Conditions
- Acute BronchitisChronic Bronchitis
- Interventions
- Drug: YHD001 dose level 1Drug: YHD001 dose level 2Drug: Pelargonium sidoides extractDrug: placebo
- First Posted Date
- 2011-08-19
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 118
- Registration Number
- NCT01420445
- Locations
- 🇰🇷
The Catholic University of Korea Seoul St. Mary'S Hospital, Seoul, Korea, Republic of
Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT01419470
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 239
- Registration Number
- NCT01400828
- Locations
- 🇰🇷
Yonsei University college of Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath